spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Galderma 

 HSMN NewsFeed - 14 Sep 2023
Galderma Launches Advanced New Serum with Alastin Skincare(R) - C-Radical Defense Antioxidant Serum
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 30 Aug 2022
Rafa Receives FDA Approval For Life-saving Midazolam Autoinjector
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 24 Mar 2021
Bioniz Therapeutics Appoints Dr. Alexandre Kaoukhov to Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Feb 2021
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
Devices Dermatology FDA
 HSMN NewsFeed - 5 May 2020
Galderma Receives FDA Approval For Restylane(R) Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
Devices Dermatology FDA
 HSMN NewsFeed - 5 Nov 2018
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
Devices Dermatology FDA
 HSMN NewsFeed - 26 Oct 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 21 May 2018
Nestlé Skin Health Announces the FDA Approval of Restylane(R) Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
Devices Dermatology FDA
 HSMN NewsFeed - 24 Mar 2017
Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 12 Dec 2016
Galderma Announces FDA Approval of Restylane(R) Refyne and Restylane(R) Defyne Dermal Fillers for Treatment of "Laugh Lines"
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 23 Aug 2016
Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep(R) Oral Solution And Confirms Patent Challenge For Generic Version Of Mirvaso(R) Gel
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 10 Jun 2016
Galderma Celebrates 20th Global Anniversary of Restylane(R)
Biopharmaceuticals Devices Dermatology
 HSMN NewsFeed - 26 Feb 2016
Galderma Delivers Innovation In Dermal Fillers With The Launch Of Two First-In-Class FDA Pivotal Phase III Trials
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Jan 2016
ZELTIQ Announces Executive Leadership Addition and Global Commercial Operations Realignment
Devices Dermatology Personnel
 HSMN NewsFeed - 11 Jan 2016
Galderma Laboratories, L.P. Appoints Miles Harrison as Leader of U.S. and Canada
Biopharmaceuticals Devices Dermatology Personnel
 HSMN NewsFeed - 7 Oct 2015
Novan Appoints Chief Financial Officer and Chief Commercial Officer to Leadership Team
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 2 Jul 2015
Galderma Receives FDA Approval to Market Restylane(R) Lyft with Lidocaine to Correct Age Related Volume Loss in the Cheek Area
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 17 Feb 2015
Galderma Announces Availability of Soolantra(R) (ivermectin) Cream, 1%
Biopharmaceuticals Dermatology FDA Product Launch
 HSMN NewsFeed - 20 Jan 2015
NovaBay Expands Sales Force for Avenova
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 11 Jul 2014
Ipsen and Galderma become exclusive partners for development and marketing of neurotoxins in the US, Canada, Brazil and Europe1
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 26 Feb 2014
Mirvaso(R) (brimonidine) the First and Only Treatment Targeting the Facial Redness of Rosacea Approved by the European Commission
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 4 Feb 2014
Bioventus Acquires DUROLANE(R) assets from Galderma
Devices Orthopaedic Acquisitions
 HSMN NewsFeed - 26 Aug 2013
Galderma Receives FDA Approval of Mirvaso(R): the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 23 Apr 2013
Nuvo Research announces European launch of Pliaglis(R) by Galderma
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 11 Mar 2013
NovaBay Names Keith Bley as Senior Vice President of Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2012
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 22 Oct 2012
Nuvo and Galderma Announce FDA Approval of Pliaglis(R)
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 13 Sep 2012
NovaBay's NeutroPhase(R) Used in New Therapeutic Technique for Management of Necrotizing Fasciitis
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 10 Apr 2012
Ellman International, Inc. Appoints Dave Pfeiffer as Chief Commercial Officer
Devices Personnel
 HSMN NewsFeed - 21 Feb 2012
Pliaglis(R) Regulatory Update
Biopharmaceuticals
 HSMN NewsFeed - 14 Oct 2011
NovaBay Pharmaceuticals Spotlights NeutroPhase(R) at the Symposium on Advanced Wound Care (SAWC)
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 4 Oct 2011
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2011
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 28 Sep 2011
NovaBay Pharmaceuticals Names Russell A. Hoon as Vice President of Its Advanced Wound Care Business Unit
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 16 Jun 2011
NovaBay Regains Worldwide Rights to Its Aganocide Compounds From Alcon
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Oct 2010
NovaBay Pharmaceuticals Appoints Gail Maderis, BayBio President and CEO and Former Genzyme Senior Executive, to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2010
Signum Biosciences Names Braham Shroot as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2010
Teva Announces Launch of Generic Differin(R)
Biopharmaceuticals Generics Dermatology FDA
 HSMN NewsFeed - 19 Oct 2009
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2009
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 10 Sep 2009
QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena(TM) (Ospemifene Tablets) in Treatment of Postmenopausal Vaginal Atrophy
Biopharmaceuticals
 HSMN NewsFeed - 3 Aug 2009
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2009
Onset Therapeutics Announces Additions to Senior Management Team
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 26 Jun 2009
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 7 Apr 2009
Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
Biopharmaceuticals Urology
 HSMN NewsFeed - 31 Mar 2009
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 25 Mar 2009
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 3 Feb 2009
Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 2 Feb 2009
The Health Authorities of 15 European Countries Give a Collective Green Light to Azzalure For the Treatment of Glabellar Lines, Paving the Way for National Marketing Authorizations
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 27 Jan 2009
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 29 Jul 2008
European Commission Grants Marketing Authorization for MediGene's Drug Oracea
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 16 Jun 2008
Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2008
QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
Biopharmaceuticals
 HSMN NewsFeed - 10 Mar 2008
ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Mar 2008
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 26 Feb 2008
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 26 Feb 2008
Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 6 Dec 2007
Ipsen Grants Galderma Exclusive Rights to Promote and Distribute Dysport(R) in Aesthetic Medicine and Dermatological Indications in Brazil, Argentina and Paraguay
Biopharmaceuticals Distribution Dermatology
 HSMN NewsFeed - 20 Nov 2007
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 18 Sep 2007
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2007
Anika Therapeutics Receives FDA Approval for ELEVESS(TM) Product
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 20 Jun 2007
FDA Approves Differin(R) (adapalene) Gel, 0.3% for Acne
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 16 May 2007
Barrier Therapeutics Appoints Dr. Braham Shroot, Dermatology Expert, as New Chief Scientific Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 7 May 2007
CollaGenex Pharmaceuticals Discontinues 40 mg Cohort of Phase II Dose-Finding Study of Incyclinide for the Treatment of Acne
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 May 2007
CollaGenex Pharmaceuticals Provides Update on 40 mg Cohort of Phase II Dose-Finding Study of Incyclinide for the Treatment of Acne
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Apr 2007
Anika Therapeutics Receives CE Mark Approval for its Cosmetic Tissue Augmentation Product ELEVESS(TM) to be Marketed by Galderma
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 2 Feb 2007
Positive Results of Phase 4 Clinical Study Evaluating Effects of Oracea(TM) (doxycycline, USP) Capsules, 40 mg, in Combination with MetroGel(R) (metronidazole gel), 1%, as Treatment for Rosacea Presented at Annual Meeting of the AAD
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Jan 2007
Galderma USA Introduces New Kit For Rosacea Treatment
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 21 Dec 2006
Anika Therapeutics Receives FDA Approval for Its Cosmetic Tissue Augmentation Product
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 7 Nov 2006
SkinMedica and Galderma to Co-Promote Desonate(TM)
Biopharmaceuticals Dermatology
Return to NewsFeed  

 Additional items found! 23

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 23 additional stories matching:
Galderma
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.